Cargando…

Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate

BACKGROUND: Tigilanol tiglate (TT) is a novel small molecule for intratumoral treatment of nonmetastatic mast cell tumors (MCTs) in dogs. In a randomized controlled clinical study, 75% of dogs that received a single TT treatment achieved complete resolution of the MCT by 28 days, with no recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reddell, Paul, De Ridder, Thomas R., Morton, John M., Jones, Pamela D., Campbell, Justine E., Brown, Graham, Johannes, Chad M., Schmidt, Peter F., Gordon, Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848365/ https://www.ncbi.nlm.nih.gov/pubmed/33438258 http://dx.doi.org/10.1111/jvim.16009

Ejemplares similares

Recurrence‐free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate
por: Jones, Pamela D., et al.
Publicado: (2020)

Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC‐46)
por: De Ridder, Thomas R., et al.
Publicado: (2020)

Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate
por: Brown, Graham K., et al.
Publicado: (2021)

Tigilanol Tiglate-Mediated Margins: A Comparison With Surgical Margins in Successful Treatment of Canine Mast Cell Tumours
por: De Ridder, Thomas, et al.
Publicado: (2021)

Treatment of multiple synchronous canine mast cell tumours using intratumoural tigilanol tiglate
por: Brown, Graham K., et al.
Publicado: (2022)

Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
por: De Ridder, Thomas, et al.
Publicado: (2020)

Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors
por: Miller, Jane, et al.
Publicado: (2019)

Identification of Gene Biomarkers for Tigilanol Tiglate Content in Fontainea picrosperma
por: Mitu, Shahida A, et al.
Publicado: (2022)

Activation of PKC supports the anticancer activity of tigilanol tiglate and related epoxytiglianes
por: Cullen, Jason K., et al.
Publicado: (2021)

Antimicrobials in dog‐to‐dog bite wounds: A retrospective study of 1526 dog bite events (1999‐2019)
por: Kalnins, Nicole J., et al.
Publicado: (2022)

Progressive cutaneous viral pigmented plaques in three Hungarian Vizslas and the response of lesions to topical tigilanol tiglate gel
por: Hansen, Naomi, et al.
Publicado: (2017)

Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)
por: Panizza, Benedict J., et al.
Publicado: (2019)

Outcomes of adjunctive radiation therapy for the treatment of mast cell tumors in dogs and assessment of toxicity: A multicenter observational study of 300 dogs
por: Mason, Sarah L., et al.
Publicado: (2021)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs
por: Burton, J.H., et al.
Publicado: (2015)

Effects of Silk Sericin on Incision Wound Healing in a Dorsal Skin Flap Wound Healing Rat Model
por: Ersel, Murat, et al.
Publicado: (2016)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine
por: Weishaar, K.M., et al.
Publicado: (2017)

Mast Cells Regulate Wound Healing in Diabetes
por: Tellechea, Ana, et al.
Publicado: (2016)

Mast Cells in Diabetes and Diabetic Wound Healing
por: Dong, Jie, et al.
Publicado: (2020)

Relationship between Device Size and Body Weight in Dogs with Patent Ductus Arteriosus Undergoing Amplatz Canine Duct Occluder Deployment
por: Wesselowski, S., et al.
Publicado: (2017)

Toxicity, outcome, and management of anthracycline overdoses in 16 dogs
por: Lawson, Haylie C., et al.
Publicado: (2021)

Long‐term survival of dogs treated for gallbladder mucocele by cholecystectomy, medical management, or both
por: Parkanzky, Max, et al.
Publicado: (2019)

Effects of desmopressin acetate administration in healthy dogs receiving prednisolone
por: Galati, Pamela, et al.
Publicado: (2021)

Radiographic quantification of left atrial size in dogs with myxomatous mitral valve disease
por: Lam, Christopher, et al.
Publicado: (2021)

Evaluation of the Cortisol‐to‐ACTH Ratio in Dogs with Hypoadrenocorticism, Dogs with Diseases Mimicking Hypoadrenocorticism and in Healthy Dogs
por: Boretti, F.S., et al.
Publicado: (2015)

Targeted sequencing of candidate gene regions for myelofibrosis in dogs
por: Campbell, Amelia G., et al.
Publicado: (2022)

Infrared Thermography in Dogs with Mammary Tumors and Healthy Dogs
por: Pavelski, M., et al.
Publicado: (2015)

Epidemiologic evaluation of calcium oxalate urolithiasis in dogs in the United States: 2010‐2015
por: Hunprasit, Vachira, et al.
Publicado: (2019)

Anatomy, baseline characteristics, and procedural outcome of patent ductus arteriosus in German Shepherd dogs
por: Wesselowski, Sonya, et al.
Publicado: (2018)

Right ventricular size and function evaluated by various echocardiographic indices in dogs with pulmonary hypertension
por: Feldhütter, Elisabeth K., et al.
Publicado: (2022)

Intracardiac heartworms in dogs: Clinical and echocardiographic characteristics in 72 cases (2010‐2019)
por: Romano, Abigail E., et al.
Publicado: (2020)

Atrioventricular accessory pathways in 89 dogs: Clinical features and outcome after radiofrequency catheter ablation
por: Wright, Kathy N., et al.
Publicado: (2018)

Alloimmunization of a dog erythrocyte antigen 1− dog transfused with weakly dog erythrocyte antigen 1+ blood
por: Guidetti, Maryline, et al.
Publicado: (2019)

Dominant outflow vein occlusion in the management of naturally occurring peripheral arteriovenous anomalies in cats and dogs
por: Hyndman, Philip S., et al.
Publicado: (2021)

Sensitivity and specificity of microRNA‐122 for liver disease in dogs
por: Oosthuyzen, W., et al.
Publicado: (2018)

Utility of vertebral left atrial size and vertebral heart size to aid detection of congestive heart failure in dogs with respiratory signs
por: Ross, Evan S., et al.
Publicado: (2023)

Reproducibility of echocardiographic indices of left atrial size in dogs with subclinical myxomatous mitral valve disease
por: Hsue, Weihow, et al.
Publicado: (2020)

Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double‐masked, randomized clinical trial
por: Lourenço, Bianca N., et al.
Publicado: (2020)

Extraesophageal reflux and reflux aspiration in dogs with respiratory diseases and in healthy dogs
por: Kouki, Sirkku, et al.
Publicado: (2023)

Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of gastrointestinal stromal tumors of dogs
por: Berger, Erika P., et al.
Publicado: (2018)

Involvement of mast cell chymase in burn wound healing in hamsters
por: DONG, XIANGLIN, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8mis8hburfrg82opng9nhshkp1